Function of histone deacetylase inhibitors in inflammation - PubMed (original) (raw)
Review
Function of histone deacetylase inhibitors in inflammation
Aleksander M Grabiec et al. Crit Rev Immunol. 2011.
Abstract
Histone deacetylases (HDACs) display multi-faceted roles in coordinating the interaction of intracellular signaling pathways with chromatin remodeling and transcription factor function to finely specify gene alterations and maintenance of gene expression during cellular activation, proliferation, and differentiation. These processes, epigenetic and non-epigenetic, are critical to the development of both the adaptive and innate arms of the mammalian immune system, and the measured initiation and resolution of immune responses. Pharmacological modulators of HDAC activity have demonstrated uniformly potent anti-inflammatory effects in experimental animal models of these diseases, in relevant immune and stromal cell populations from patients, as well as initial successes in the clinic. Recent studies have identified key roles for specific HDACs in regulating immune function, as well as alterations in HDAC expression and function in a number of immune-mediated inflammatory diseases (IMIDs), which may contribute to pathology in these diseases. Here, we review recent advances in our understanding of HDAC function in the immune system, their contribution to IMIDs, and the therapeutic potential of altering HDAC activity in IMIDs.
Similar articles
- Restoring T Cell Tolerance, Exploring the Potential of Histone Deacetylase Inhibitors for the Treatment of Juvenile Idiopathic Arthritis.
Nijhuis L, Peeters JGC, Vastert SJ, van Loosdregt J. Nijhuis L, et al. Front Immunol. 2019 Feb 7;10:151. doi: 10.3389/fimmu.2019.00151. eCollection 2019. Front Immunol. 2019. PMID: 30792714 Free PMC article. Review. - Histone deacetylases as regulators of inflammation and immunity.
Shakespear MR, Halili MA, Irvine KM, Fairlie DP, Sweet MJ. Shakespear MR, et al. Trends Immunol. 2011 Jul;32(7):335-43. doi: 10.1016/j.it.2011.04.001. Epub 2011 May 12. Trends Immunol. 2011. PMID: 21570914 Review. - Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs.
Cantley MD, Haynes DR. Cantley MD, et al. Inflammopharmacology. 2013 Aug;21(4):301-7. doi: 10.1007/s10787-012-0166-0. Epub 2013 Jan 23. Inflammopharmacology. 2013. PMID: 23341163 Review. - Epigenetic regulation of airway inflammation.
Adcock IM, Tsaprouni L, Bhavsar P, Ito K. Adcock IM, et al. Curr Opin Immunol. 2007 Dec;19(6):694-700. doi: 10.1016/j.coi.2007.07.016. Epub 2007 Aug 27. Curr Opin Immunol. 2007. PMID: 17720468 Review. - Histone deacetylases as targets in autoimmune and autoinflammatory diseases.
Hamminger P, Rica R, Ellmeier W. Hamminger P, et al. Adv Immunol. 2020;147:1-59. doi: 10.1016/bs.ai.2020.06.001. Epub 2020 Jul 15. Adv Immunol. 2020. PMID: 32981634
Cited by
- Estrogen receptor α/HDAC/NFAT axis for delphinidin effects on proliferation and differentiation of T lymphocytes from patients with cardiovascular risks.
Dayoub O, Le Lay S, Soleti R, Clere N, Hilairet G, Dubois S, Gagnadoux F, Boursier J, Martínez MC, Andriantsitohaina R. Dayoub O, et al. Sci Rep. 2017 Aug 24;7(1):9378. doi: 10.1038/s41598-017-09933-4. Sci Rep. 2017. PMID: 28839227 Free PMC article. - Restoring T Cell Tolerance, Exploring the Potential of Histone Deacetylase Inhibitors for the Treatment of Juvenile Idiopathic Arthritis.
Nijhuis L, Peeters JGC, Vastert SJ, van Loosdregt J. Nijhuis L, et al. Front Immunol. 2019 Feb 7;10:151. doi: 10.3389/fimmu.2019.00151. eCollection 2019. Front Immunol. 2019. PMID: 30792714 Free PMC article. Review. - Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay.
Grabiec AM, Korchynskyi O, Tak PP, Reedquist KA. Grabiec AM, et al. Ann Rheum Dis. 2012 Mar;71(3):424-31. doi: 10.1136/ard.2011.154211. Epub 2011 Sep 27. Ann Rheum Dis. 2012. PMID: 21953341 Free PMC article. - Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiency.
Bouchecareilh M, Hutt DM, Szajner P, Flotte TR, Balch WE. Bouchecareilh M, et al. J Biol Chem. 2012 Nov 2;287(45):38265-78. doi: 10.1074/jbc.M112.404707. Epub 2012 Sep 20. J Biol Chem. 2012. PMID: 22995909 Free PMC article. - Activation of Class I histone deacetylases contributes to mitochondrial dysfunction in cardiomyocytes with altered complex activities.
Lkhagva B, Kao YH, Lee TI, Lee TW, Cheng WL, Chen YJ. Lkhagva B, et al. Epigenetics. 2018;13(4):376-385. doi: 10.1080/15592294.2018.1460032. Epub 2018 May 3. Epigenetics. 2018. PMID: 29613828 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical